Together with the Amalia Children’s hospital and Stichting Kind en Ziekenhuis, Chris Verhaak (Medical Psychology, theme Mitochondrial diseases) received a grant of 450.000 euro from Zorginstituut Nederland for the project TRANSIT.
|TRANSIT: Transmural care and interdisciplinary collaboration for children with chronic medical conditions and psychosocial comorbidity|
|One out of four children with a severe medical condition also shows vulnerability from a psychosocial perspective. They are limited in school attendance and have significant delays in reaching developmental milestones. In addition, they, as well as their family, have difficulties implementing disease management tasks into daily life, negatively impacting their health outcomes. The TRANSIT project aims to improve interdisciplinary care and collaboration between healthcare professionals in the Amalia Children’s Hospital as well as in primary care. In close collaboration with children and their parents, a digital environment will be developed, providing an interdisciplinary treatment plan and information about the psychosocial impact of the disease in daily life. In addition, the digital environment will support interdisciplinary and transmural communication and consultation. During the course of the project, health care use will be monitored as well as children’s participation in school and sick leave of the parents.
The project closely fits with recent developments in child care in the Netherlands (Medical Child Care system), as well as Amalia plan to implementing organization of care from the perspective of the patient
Related news items
Nontuberculous mycobacteria and fungal co-infections Bonnie and Clyde?18 April 2019
In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.read more
ESCMID award for groundbreaking studies on NTM disease18 April 2019
Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.read more
Dosing anticancer drugs in patients with renal or hepatic impairment11 April 2019
Renal or hepatic impairment is a common comorbidity for patients with cancer either because of the disease itself, toxicity of previous anticancer treatments, or because of other factors affecting organ function, such as increased age.read more